IMPDH2 and Ewing sarcoma: Importantly, the present study provides comprehensive evidence that the IMPDH2 inhibitor AVN944 exerts potent anti-proliferative and anti-clonogenic effects against two Ewing's sarcoma cell lines, TC71 and SK-ES-1.